Your browser doesn't support javascript.
loading
Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan.
Kanemasa, Hikaru; Nanishi, Etsuro; Takada, Hidetoshi; Ishimura, Masataka; Nishio, Hisanori; Honjo, Satoshi; Masuda, Hiroshi; Nagai, Noriko; Nishihara, Takahiro; Ishii, Tohru; Adachi, Takenori; Hara, Satoshi; Lin, Lisheng; Tomita, Yoshie; Kamizono, Junji; Komiyama, Osamu; Kohdera, Urara; Tanabe, Saori; Sato, Atsuo; Hida, Shinya; Yashiro, Mayumi; Makino, Nobuko; Nakamura, Yosikazu; Hara, Toshiro; Ohga, Shouichi.
Afiliación
  • Kanemasa H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nanishi E; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Takada H; Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ishimura M; Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Nishio H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Honjo S; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Masuda H; Department of Pediatrics, National Hospital Organization Fukuoka National Hospital, Fukuoka, Japan.
  • Nagai N; Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Nishihara T; Department of Pediatrics, Okazaki City Hospital, Okazaki, Japan.
  • Ishii T; Department of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Adachi T; Department of Pediatrics, National Hospital Organization Tochigi Medical Center, Utsunomiya, Japan.
  • Hara S; Department of Pediatrics, Tosei General Hospital, Seto, Japan.
  • Lin L; Department of Pediatrics, Juntendo University Urayasu Hospital, Urayasu, Japan.
  • Tomita Y; Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Kamizono J; Department of Pediatrics, Kitakyusyu Municipal Yahata Hospital, Kitakyushu, Japan.
  • Komiyama O; Department of Pediatrics, Kitakyusyu Municipal Yahata Hospital, Kitakyushu, Japan.
  • Kohdera U; Department of Pediatrics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Tanabe S; Department of Pediatrics, Nakano Children's Hospital, Osaka, Japan.
  • Sato A; Department of Pediatrics, Nihonkai General Hospital, Sakata, Japan.
  • Hida S; Department of Pediatrics, Yokohama Rosai Hospital, Yokohama, Japan.
  • Yashiro M; Department of Pediatrics, Osaka Red Cross Hospital, Osaka, Japan.
  • Makino N; Department of Public Health, Jichi Medical University, Shimotsuke, Japan.
  • Nakamura Y; Department of Public Health, Jichi Medical University, Shimotsuke, Japan.
  • Hara T; Department of Public Health, Jichi Medical University, Shimotsuke, Japan.
  • Ohga S; Fukuoka Children's Hospital, Fukuoka, Japan.
Front Pediatr ; 9: 597458, 2021.
Article en En | MEDLINE | ID: mdl-34354966
Background: Arthritis may occur after the diagnosis of Kawasaki disease (KD). Most cases are self-limiting; however, some patients require prolonged treatment. Method: To characterize KD-related arthritis, 14 patients who required arthritis treatment within 30 days after the diagnosis of KD were recruited from the 23rd KD survey in Japan. Twenty-six additional patients were included from our tertiary center and literature review cohorts. Results: The estimated prevalence of KD-related arthritis in Japan was 48 per 100,000 KD patients. Patients with KD-related arthritis had an older age at onset (52 vs. 28 months, P = 0.002) and higher rate of intravenous immunoglobulin (IVIG) resistance in comparison to those without arthritis (86 vs. 17%, P < 0.001). Among 40 patients, 18 had arthritis in the acute phase KD (continued fever-onset type) and 22 did in the convalescent phase (interval fever-onset type). Both showed a similar rate of complete KD or IVIG response. Interval-type patients required biologics for arthritis control less frequently (5 vs. 39%, P = 0.02) and had a higher 2-year off-treatment rate (100 vs. 43%, P = 0.009) than continued-type ones. Interval-types showed lower serum ferritin and interleukin-18 levels than continued-types. When continued-types were grouped according to whether or not they required biologics (n = 7 and n = 11, respectively), the former subgroup had higher ferritin and interleukin-18 levels (P = 0.01 and 0.02, respectively). A canonical discriminant analysis differentiated interval-type from continued-type with the combination of age, time to arthritis, and the ferritin and matrix metalloproteinase-3 levels. Conclusion: Arthritis requiring treatment is a rare complication of KD. KD-associated arthritis includes interval-type (KD-reactive) and continued-type (true systemic-onset juvenile idiopathic arthritis [JIA] requiring biologics), and overlapping arthritis, suggesting the pathophysiological continuity of autoinflammation between KD and JIA.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Japón